Stock Track | Zymeworks Soars 5.45% Intraday on Positive Analyst Ratings and Price Target Increases

Stock Track

03/04

Zymeworks Inc (ZYME) saw its stock price surge 5.45% during Tuesday's intraday trading session, driven by a wave of positive analyst sentiment.

Multiple financial institutions issued favorable ratings on the healthcare stock, with Leerink Partners maintaining an Outperform rating, Truist Financial reiterating a Buy rating with a $40 price target, and Stifel Nicolaus reaffirming a Buy rating. Notably, Stifel raised its price target for Zymeworks from $40 to $47, indicating increased confidence in the company's future performance.

The collective bullish outlook from analysts appears to have boosted investor confidence, leading to significant buying pressure and the stock's substantial intraday gain.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1154856625"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1154856625\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1154856625?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-04 03:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154856625","market":"nz","top_or_hot":-1,"title":"Stock Track | Zymeworks Soars 5.45% Intraday on Positive Analyst Ratings and Price Target Increases","media":"Stock Track","content":"<p>Zymeworks Inc (ZYME) saw its stock price surge 5.45% during Tuesday's intraday trading session, driven by a wave of positive analyst sentiment.</p><p>Multiple financial institutions issued favorable ratings on the healthcare stock, with Leerink Partners maintaining an Outperform rating, Truist Financial reiterating a Buy rating with a $40 price target, and Stifel Nicolaus reaffirming a Buy rating. Notably, Stifel raised its price target for Zymeworks from $40 to $47, indicating increased confidence in the company's future performance.</p><p>The collective bullish outlook from analysts appears to have boosted investor confidence, leading to significant buying pressure and the stock's substantial intraday gain.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Zymeworks Soars 5.45% Intraday on Positive Analyst Ratings and Price Target Increases</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Zymeworks Soars 5.45% Intraday on Positive Analyst Ratings and Price Target Increases\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-03-04 03:24</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Zymeworks Inc (ZYME) saw its stock price surge 5.45% during Tuesday's intraday trading session, driven by a wave of positive analyst sentiment.</p><p>Multiple financial institutions issued favorable ratings on the healthcare stock, with Leerink Partners maintaining an Outperform rating, Truist Financial reiterating a Buy rating with a $40 price target, and Stifel Nicolaus reaffirming a Buy rating. Notably, Stifel raised its price target for Zymeworks from $40 to $47, indicating increased confidence in the company's future performance.</p><p>The collective bullish outlook from analysts appears to have boosted investor confidence, leading to significant buying pressure and the stock's substantial intraday gain.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZYME","symbol_name":"ZYMEWORKS INC (US)","start_time":0,"source_url":"","article_id":"1154856625","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154856625","pubTimestamp":1772565882,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Zymeworks Inc (ZYME) saw its stock price surge 5.45% during Tuesday's intraday trading session, driven by a wave of positive analyst sentiment.Multiple financial institutions issued favorable ratings...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ZYME":"ZYMEWORKS INC (US)"},"translate_title":"个股追踪|Zymeworks盘中大涨5.45%，因分析师正面评级和目标价上调","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZYME":1},"content_text":"Zymeworks Inc (ZYME) saw its stock price surge 5.45% during Tuesday's intraday trading session, driven by a wave of positive analyst sentiment.Multiple financial institutions issued favorable ratings on the healthcare stock, with Leerink Partners maintaining an Outperform rating, Truist Financial reiterating a Buy rating with a $40 price target, and Stifel Nicolaus reaffirming a Buy rating. Notably, Stifel raised its price target for Zymeworks from $40 to $47, indicating increased confidence in the company's future performance.The collective bullish outlook from analysts appears to have boosted investor confidence, leading to significant buying pressure and the stock's substantial intraday gain.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}